News

HIHG Awarded up to $30.2 Million in Alzheimer’s Disease Research Funding

Read more »

The Alzheimer’s disease Follow-Up Study research team during a study meeting. From left, Brian Kunkle, Ph.D., Jeffery Vance, M.D., Ph.D., Katrina Celis Delgado, M.D., Margaret Pericak-Vance, Ph.D., Larry Deon Adams, and Michael Cuccaro, Ph.D. Delgado and Adams are clinical coordinators for the HIHG diversity studies.

Miller School and Collaborators to Receive up to $30.2 Million for Alzheimer’s Research

The University of Miami Miller School of Medicine and collaborators have been selected to receive awards totaling up to $30.2 million in grant funding for Alzheimer’s disease research. The awards include a grant expected to total $22.7 million over five years and a second grant for $7.5 million. Both awards were given by the National Institute on Aging, part of the National Institutes of Health.

Read more »

UM Med Selected for NIH Program & Awarded $4.45 Million Collaboration Grant

Read more »

The science of gene editing has been advancing more rapidly than have ethical guidelines for its use, say experts.

New Ethics Guidelines for Gene Editing

On August 3, The American Journal of Human Genetics published the American Society for Human Genetics’ policy statement on germline gene editing in humans. Representing the Miller School on the task force was Rosario Isasi, J.D., M.P.H., a bioethicist and lawyer whose work focuses on the regulation of human genetic technologies. We asked Isasi to discuss the policy statement and its broad implications.

Read more »

Our Researchers Attend the Alzheimer's Association International Conference 2017

Read more »